Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P4HB | P07237 | 5/20 | 0.88 |
| ▸ | POLB | P06746 | 3/20 | 0.88 |
| ▸ | GAA | P10253 | 3/20 | 0.88 |
| ▸ | XDH | P47989 | 2/20 | 0.88 |
| ▸ | APEX1 | P27695 | 2/20 | 0.88 |
| ▸ | RECQL | P46063 | 2/20 | 0.88 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.88 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.78 |
| ▸ | MAPT | P10636 | 2/20 | 0.78 |
| ▸ | HES1 | Q14469 | 2/20 | 0.78 |
| ▸ | FANCF | Q9NPI8 | 2/20 | 0.78 |
| ▸ | KDM1A | O60341 | 1/20 | 0.78 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.78 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.78 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.78 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.78 |
| ▸ | CFTR | P13569 | 1/20 | 0.78 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.78 |
| ▸ | MAOA | P21397 | 1/20 | 0.78 |
| ▸ | ACHE | P22303 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mauritianin SCHEMBL30003610 | 1.00 | P4HB (0.88) | P4HBPOLBGAAXDHAPEX1 | |
| Mauritianin SCHEMBL572331 | 1.00 | P4HB (0.88) | P4HBPOLBGAAXDHAPEX1 | |
| Mauritianin SCHEMBL3746601 | 1.00 | P4HB (0.88) | P4HBPOLBGAAXDHAPEX1 | |
| Mauritianin SCHEMBL18167030 | 1.00 | P4HB (0.88) | P4HBPOLBGAAXDHAPEX1 | |
| SCHEMBL29436868 | 0.98 | P4HB (0.84) | P4HBPOLBGAAXDHAPEX1 | |
| Camelliaside A SCHEMBL29882538 | 0.97 | P4HB (0.83) | P4HBPOLBGAAXDHAPEX1 | |
| Camelliaside A SCHEMBL14813695 | 0.97 | P4HB (0.83) | P4HBPOLBGAAXDHAPEX1 | |
| Camelliaside A SCHEMBL13328501 | 0.97 | P4HB (0.83) | P4HBPOLBGAAXDHAPEX1 | |
| Camelliaside A SCHEMBL30637486 | 0.97 | P4HB (0.83) | P4HBPOLBGAAXDHAPEX1 | |
| SCHEMBL22678451 | 0.97 | P4HB (0.88) | P4HBPOLBGAAXDHAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250169516-A1 | METHODS, DEVICES AND COMPOSITIONS FOR PRESERVING HUMAN MILK | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-05-29 | — | — | US | disclosed |
| CN-119639835-A | Preparation method of keemun camellia seed fermented oil | 广州中妆美业化妆品有限公司 | 2025-03-18 | — | — | CN | disclosed |
| US-12239142-B2 | Methods, devices and compositions for preserving human milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-03-04 | — | — | US | disclosed |
| US-20250032448-A1 | COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES | KOH, Hwee Ling (SG) | 2025-01-30 | — | — | US | disclosed |
| US-12144797-B2 | Compound for use in the treatment and/or prevention of parasitic mediated diseases | KOH, Hwee Ling (SG) | 2024-11-19 | — | — | US | disclosed |
| US-20240268402-A1 | Methods, Devices and Compositions for Preserving Human Milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2024-08-15 | — | — | US | disclosed |
| EP-3389649-B1 | FURANOCOUMARINS FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES | LEEWARD PACIFIC PTE LTD (SG) | 2020-10-21 | — | — | EP | disclosed |
| US-20190046503-A1 | COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES | LEEWARD PACIFIC PTE LTD (SG) | 2019-02-14 | — | — | US | disclosed |
| EP-3389649-A1 | COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES | Leeward Pacific Pte Ltd (SG) | 2018-10-24 | — | — | EP | disclosed |
| US-20140234271-A1 | COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS | THE HOSPITAL FOR SICK CHILDREN (CA) | 2014-08-21 | — | — | US | disclosed |
| US-8748177-B2 | Compositions for proliferation of cells and related methods | THE HOSPITAL FOR SICK CHILDREN (CA) | 2014-06-10 | — | — | US | disclosed |
| US-20140155961-A1 | METHODS OF TREATING SKIN | Tracie Martyn International, Inc. (US) | 2014-06-05 | — | — | US | disclosed |
| EP-2598150-A2 | COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS | The Hospital For Sick Children (CA) | 2013-06-05 | — | — | EP | disclosed |
| WO-2012018643-A2 | COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS | THE HOSPITAL FOR SICK CHILDREN (CA) | 2012-02-09 | — | — | WO | disclosed |
| US-20110301105-A1 | COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS | THE HOSPITAL FOR SICK CHILDREN (CA) | 2011-12-08 | — | — | US | disclosed |
| US-20100272790-A1 | Methods of Treating Skin | TRACIE MARTYN INTERNATIONAL, LLC (US) | 2010-10-28 | — | — | US | disclosed |
| US-7776915-B2 | Topical formulations and methods of use | TRACIE MARTYN INTERNATIONAL, LLC (US) | 2010-08-17 | — | — | US | disclosed |
| WO-2010039679-A1 | COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS | THE HOSPITAL FOR SICK CHILDREN (CA) | 2010-04-08 | — | — | WO | disclosed |
| US-20060216251-A1 | Topical formulations and methods of use | TRACIE MARTYN INTERNATIONAL, LLC (US) | 2006-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | LPL, CEL, LPO | P4HB 1596/4885POLB 1376/4885GAA 446/4885 |
| US-20140155961-A1 | METHODS OF TREATING SKIN | CUTA, LIPA, DLAT | P4HB 3344/4885POLB 1760/4885GAA 907/4885 |
| US-20100272790-A1 | Methods of Treating Skin | CUTA, LIPA, DLAT | P4HB 3344/4885POLB 1760/4885GAA 907/4885 |
| US-20190046503-A1 | COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES | ICMT, ALG3, PFN1 | P4HB 1277/4885POLB 4587/4885GAA 1179/4885 |
| US-12144797-B2 | Compound for use in the treatment and/or prevention of parasitic mediated diseases | ICMT, ALG3, PFN1 | P4HB 1277/4885POLB 4587/4885GAA 1179/4885 |
| US-20060216251-A1 | Topical formulations and methods of use | CPT1B, SLC25A20, CPT1A | P4HB 3841/4885POLB 1930/4885GAA 1450/4885 |
| US-20140234271-A1 | COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS | MKI67, KRT18, PROX1 | P4HB 3209/4885POLB 292/4885GAA 3295/4885 |
| US-20250032448-A1 | COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES | EPX, PKD2, MPO | P4HB 2187/4885POLB 4006/4885GAA 115/4885 |
| US-20110301105-A1 | COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS | MKI67, KRT18, PROX1 | P4HB 3209/4885POLB 292/4885GAA 3295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.